Certara Welcomes New Expertise to its Board
Certara, Inc., a leading force in model-informed drug development, recently announced the appointment of John Reynders, PhD, to its Board of Directors. This decision underscores Certara's commitment to strengthening its leadership and enhancing the impact of its innovative solutions in the pharmaceutical industry.
John Reynders: A Pioneer in Pharmaceutical Science
With a remarkable career spanning over 25 years, Dr. Reynders is well-equipped to contribute to Certara's objectives. His extensive experience in the pharmaceutical and technology sectors has positioned him as an influential figure in the field. Notably, he served as the founding Chief Information Officer of Moderna, where he pioneered the data-science strategies that led to the successful design of mRNA therapies.
In his most recent role, Dr. Reynders was the Chief Data Sciences Officer at Neumora, a biotech company dedicated to addressing brain diseases. His portfolio also includes key leadership positions at renowned organizations such as Alexion Pharmaceuticals, AstraZeneca, Johnson & Johnson, Eli Lilly, and Celera, where he was instrumental in guiding data-sciences and technology initiatives.
Transformational Insights for Certara
The addition of Dr. Reynders to Certara's Board is celebrated by the company's CEO William F. Feehery, PhD, who expressed enthusiasm about the wealth of knowledge that Dr. Reynders brings. His expertise in artificial intelligence, data science, and the life sciences will be invaluable as Certara continues to innovate by developing robust software and services. These advancements are aimed at expediting the discovery and development of new medicines while also enhancing the overall productivity of pharmaceutical research and development.
Strategic Growth and Development
In his own words, Dr. Reynders shared, "I am pleased to join Certara’s Board of Directors and help build on their unique biosimulation portfolio, scientific expertise, and data assets. They are at the intersection of data and life sciences which is where I’ve spent most of my career.” His vision aligns perfectly with Certara’s strategy, opening new avenues for growth and strategic development in the complex world of pharmaceuticals.
About Certara's Mission
Certara is dedicated to accelerating the development of medicines through the use of advanced biosimulation software, cutting-edge technology, and strategic services. These efforts aim to revolutionize traditional drug discovery methodologies. Certara prides itself on a broad client base, serving over 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries, reinforcing its status as an industry leader.
Looking Ahead
The integration of Dr. Reynders on the Board of Directors not only reflects Certara's forward-thinking approach but also emphasizes its goal to remain at the forefront of innovative solutions in the pharmaceutical sector. As the company continues to leverage his expertise, we can expect to see significant advancements in how new therapies are developed and brought to market.
Contacting Certara
For inquiries related to Certara, you may contact Sheila Rocchio at sheila.rocchio@certara.com. For media-related questions, Alyssa Horowitz can be reached at certara@pancomm.com.
Frequently Asked Questions
Who is John Reynders?
John Reynders, PhD, is a seasoned pharmaceutical industry leader with over 25 years of experience, recently appointed to Certara's Board of Directors.
What is Certara's core mission?
Certara focuses on accelerating the development of medicines using innovative biosimulation software and services, transforming drug discovery practices.
How will Dr. Reynders contribute to Certara?
Dr. Reynders brings extensive expertise in data science and artificial intelligence, which will support Certara's goals of innovation and productivity in drug development.
What kind of clients does Certara serve?
Certara serves more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies globally, enhancing its global reach and influence.
Where can I learn more about Certara?
Visit Certara's official website to learn more about its innovative solutions and ongoing projects in the pharmaceutical industry.